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Occupational immune diseases are new emerging illnesses
that aﬀect workers in industrialized societies. Occupational
exposures to substances in the workplace environment can
cause inﬂammation, allergy, or other potentially detrimen-
tal immune responses. Personal exposure to a variety of
chemicals can exacerbate immune diseases such as contact
dermatitis as well as respiratory diseases including rhinitis,
asthma, and hypersensitivity pneumonitis.
Next to illnesses due to repeated traumatic injury,
contact dermatitis is the second most commonly reported
occupational illness. It can prevent individuals from per-
forming job-related tasks or preclude working altogether.
Occupationally related contact dermatitis is a signiﬁcant
public health burden with combined direct annual cost
estimates of up to $1 billion in the USA for medical costs,
workers compensation, and lost time from work.
Respiratory morbidity is also a signiﬁcant burden to
public health leading to lost productivity. Prevalence rates
for occupational rhinitis are signiﬁcant, varying by occu-
pation between 5% and 65% and costing an estimated
$593/year/employee due to productivity losses. Conservative
estimates made by the American Thoracic Society in 2003
estimate that 15% of chronic obstructive pulmonary disease
and asthma cases were work related and cost approximately
$7 billion in lost productivity in the USA With the changing
work environment, new occupational hazards continue to
emerge which require immunologic characterization. In
order to reduce the morbidity and mortality associated with
these illnesses, it is critical that we identify the allergens
and understand the immunological mechanism by which
they exacerbate immune-mediated respiratory and dermal
diseases. Speciﬁc understanding of mechanism has direct
implications in developing appropriate intervention and
prevention strategies.
Occupational allergy can be stratiﬁed into high-molec-
ular-weight-allergenandlow-molecular-weight-allergenme-
diated responses. Diﬀerent immunologic mechanisms medi-
ate allergic reactivity to these occupational allergens as high-
lighted in this issue by Talini et al. High-molecular-weight
(HMW) allergens (typically proteins) induce type I hyper-
sensitivity responses or typical allergies by inducing IgE anti-
bodies which lead to a continuum of symptoms including
rhinitis (rhinosinusitis, conjunctivitis), hives, asthma, and
life-threatening anaphylaxis. Patients with HMW-allergen-
induced asthma show a greater frequency and severity of
the early-phase response but are less likely to demonstrate
a late-phase response. Occupational outbreaks of reactions
to HMW allergens can occur episodically and can be
severe and life altering for those aﬀected. These allergies
can aﬀect large numbers of easily identiﬁed workers in
speciﬁc industries which can reach epidemic proportions
such as latex allergy and Baker’s asthma. It can present
in a less-well-deﬁned population or as local occurrences
such as agricultural or food processors exposed to soy, sea
foods, pollens, molds, and so forth. Research areas include
identiﬁcationandcharacterizationofhigh-molecular-weight
occupational allergens. Using fungal enzymes as a prototypic
HMW occupational allergen, Green et al. describe some of
the characterized fungal enzyme allergens and discuss mon-
itoring and avoidance strategies. Characterization of HMW
allergens includes using proteomics, molecular techniques
andgeneratingrecombinantallergens,andproducingmono-
clonal antibodies for the development of immunoassays and
improved detection of the allergens in the workplace.2 Journal of Allergy
Low-molecular-weight allergens (typically chemicals)
inducetype4hypersensitivityreactionsbyinducingallergen-
speciﬁc T lymphocytes which can mediate contact dermatitis
reactions as well as sensitizations that can lead to severe
asthma such as isocyanates (auto painters) and trimellitic
acid. Patients with LMW-allergen-induced asthma are more
likely to demonstrate a late-phase airway response. The
review by Anderson et al. describes the identiﬁcation of low-
molecular-weight allergens in the laboratory using the local
lymphnodeassaytodeterminewhethernewchemicalsbeing
introduced can cause workplace sensitizations as well as
testing various components to identify the speciﬁc sensitizer
and potentially nonsensitizing replacements. They examined
the eﬀects of chemical exposure on immune function using
selected assays from a comprehensive tiered approach. This
can be used in detecting toxic eﬀects following chemical
exposure (in rodents) as adopted by the National Toxicology
Program. The utility of analyzing potential replacement
chemicals is highlighted by the study of Johnson et al.
where the chemical ortho-phthalaldehyde (OPA) has been
recommended as a substitute for glutaraldehyde as a ster-
ilant in the healthcare industry. Their laboratory evidence
suggested that the replacement of the chemical OPA is also
a strong sensitizer. Characterization of the biochemical and
immune mechanisms by which chemicals become allergens
(haptenization) is described in a comprehensive review by
Chipindaetal.Developingnewmethodsforscreeningchem-
icals for potential sensitizers helps to build better models by
which we predict whether chemicals are allergens. Yucesoy et
al. describe new studies aimed at identifying occupationally
sensitized individuals and understanding the genetic proﬁle
associated with sensitizing/anaphylactic agents.
It is important to improve our basic science knowledge
and understanding of occupational allergies and their patho-
genesis. If we are able to identify potential allergens, before
clinical symptoms are observed, employers can take neces-
sary precautions to minimize or eliminate their employee’s
exposure.
Acknowledgments
We dedicate this issue to one of our coeditors: Dr. Arthur
Sussman, who passed away April 6 2011, just prior to our
special issues’ publication. Arthur Sussman was a pioneer
in the ﬁeld of allergy and immunology and witnessed its
emergence ﬁrst hand during his sixty years of medical
practice. He contributed to this issue of the journal and it
is ﬁtting that this issue would highlight emerging issues in
allergy and Immunology—occupational diseases. He will be
sincerely missed.
Gordon Sussman
Donald Beezhold